Loading…
Oncotec, a medac subsidiary, unveiled a €35 million investment in a robot-controlled filling line and automatic visual inspection system for syringes at its BioPharmaPark site in Dessau-Rosslau, Germany.
“With these new installations, Oncotec is more than ready to meet the future demands and dynamic global developments in drug manufacturing at our pharma site in Dessau.”merz.com
Summarized from public sources; check the original articles before acting on it.